TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients
- Resource Type
- Journal
- Source
JOURNAL OF CUTANEOUS PATHOLOGY ; APR 2017, 44 4, p328-p337, 10p.- Subject
- Language
- English
- ISSN
- 16000560